शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
QUICKHEALNSEQuick Heal Technologies LimitedHighNeutral
Announced Thu, 29 Jan, 2026 · 21:53 IST

Quick Heal Q3 FY26 PAT jumps on enterprise growth consumer revenue dips

Revenue DeclineEbitda Margin CompressionResults View source PDFExplain this filing

QUICKHEAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.9%Reaction day
₹193.25
prior close
₹193.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.8%-4.7% vs market

On the reaction day the stock moved 4.7 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.9
10m
-4.1
15m
-4.1
30m
-2.5
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
-2.9+1.8-4.7
Next day
-5.8+0.5-6.4
2d
-4.5+4.3-8.7
3d
-2.0+5.6-7.7
4d
-4.5+4.6-9.1
5d
-7.0+3.8-10.7
1w
-1.9+7.5-9.4
15d
-7.9+3.8-11.6
1m
-17.7-0.3-17.4
2m
-34.9-9.6-25.4
3m
-14.4+9.9-24.3
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q3 FY26 results. Revenue rose 1.3 percent YoY to Rs 71.54 Cr; PAT surged to Rs 6.61 Cr from Rs 0.11 Cr. Enterprise revenue grew 37 percent YoY to Rs 38.5 Cr, while consumer revenue fell 21 percent to Rs 37.6 Cr. 9M FY26 revenue slipped 1 percent to Rs 212.29 Cr with EBITDA turning slightly negative. Company won a Rs 64 Cr government order; order book stands at Rs 80 Cr plus. Board also approved reclassification of Gagan Bharari Enterprises LLP from promoter to public category.

Likely market impact

Mixed signals: enterprise momentum and PAT recovery positive, but consumer weakness and negative 9M EBITDA raise concern.